Abstract
Background: The serum levels of Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA) and Arachidonic Acid (AA) under the state of Pressure Ulcers (PUs) are still unclear.
Introduction: In order to investigate serum levels of DHA, EPA, and AA in PUs rats, an ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/ MS) method was developed and validated.
Methods: Chromatographic separation of DHA, EPA, AA was carried out on a BEH C18 column and gradient elute consisted of 5 mM ammonium acetate-0.1% formic acid and acetonitrile. Subsequently, fifty rats were divided into five groups (n=10), four PU groups (A-D) underwent various pressure and release time protocols, with group E as the control. The concentrations of DHA, EPA, AA from five groups were determined by using a validated method.
Results: The results showed there was good linearity for DHA (327.3/283.4), EPA (301.2/257.0), and AA (303.1/258.9) within 0.05-6.4 μg/mL. In control group, the levels of DHA, AA and EPA were 1.16±0.68, 0.59±0.19 and 0.78±0.21 μg/mL. At the end of modeling, concentrations of DHA, EPA and AA were increased after long and persistent pressure (>8 h). Especially, the level of DHA was significantly higher (P<0.01) than that of control group.
Conclusion: A stable, reliable and accurate UPLC-MS/MS for determination of DHA, EPA, AA in blood was developed. Serum concentrations of DHA, EPA and AA were altered differently after long and persistent pressure (>8 h), and DHA is a remarkable one.
Keywords: UPLC-MS/MS, pressure ulcer, docosahexaenoic acid, eicosapentaenoic acid, arachidonic acid, rat.
Graphical Abstract
[http://dx.doi.org/10.1016/j.phrs.2009.10.007] [PMID: 19897038]
[http://dx.doi.org/10.1017/S0007114512001572]
[http://dx.doi.org/10.18632/oncotarget.24405] [PMID: 29545942]
[http://dx.doi.org/10.1371/journal.pone.0136542] [PMID: 26325577]
[http://dx.doi.org/10.1111/jcmm.13614] [PMID: 29602230]
[http://dx.doi.org/10.1016/S0021-9673(03)00989-0] [PMID: 12943251]
[http://dx.doi.org/10.1016/j.meatsci.2007.02.004] [PMID: 22061238]
[http://dx.doi.org/10.1007/s11745-011-3550-4] [PMID: 21461869]
[http://dx.doi.org/10.1111/iwj.12870] [PMID: 29504266]
[http://dx.doi.org/10.7326/0003-4819-158-5-201303051-00008] [PMID: 23460098]
[PMID: 21350273]
[http://dx.doi.org/10.3390/ijms17030284] [PMID: 26927073]
[http://dx.doi.org/10.1111/j.1365-2133.2009.09349.x] [PMID: 19673871]
[http://dx.doi.org/10.2174/1389450111314060011] [PMID: 23531113]
[http://dx.doi.org/10.1111/1756-185X.13051] [PMID: 28261950]
[http://dx.doi.org/10.1016/j.healun.2018.09.009] [PMID: 30352778]
[http://dx.doi.org/10.1021/acschemneuro.6b00428] [PMID: 27983793]
[http://dx.doi.org/10.1002/jps.21421] [PMID: 18428980]
[http://dx.doi.org/10.1365/s10337-009-1163-3]
[http://dx.doi.org/10.2116/analsci.32.1011] [PMID: 27682409]
[http://dx.doi.org/10.1016/S0003-2670(00)80675-3]
[http://dx.doi.org/10.1016/j.jpba.2011.01.036] [PMID: 21353430]
[http://dx.doi.org/10.1186/1476-511X-12-169] [PMID: 24195588]
[http://dx.doi.org/10.1016/j.clindermatol.2010.03.020] [PMID: 20620762]
[http://dx.doi.org/10.1007/s00059-004-2602-4] [PMID: 15580322]